Povidone Iodine Mouthwash, Gargle, Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 4, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.5490?guestAccessKey=c60aee4d-d4da-4df2-ad4e-9482ac6400c5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020421

 

What The Study Did: Researchers in this randomized clinical trial investigated whether nasopharyngeal application of povidone iodine could reduce the viral load of patients with nonsevere COVID-19 symptoms.

Authors: Olivier Mimoz, M.D., Ph.D., University Hospital of Poitiers in Poitiers, France, is the corresponding author.

 

(doi:10.1001/jamaoto.2020.5490)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

 

https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.5490?guestAccessKey=c60aee4d-d4da-4df2-ad4e-9482ac6400c5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020421